ERX Eirx Therap.

    RNS Number : 4893Y
  EiRx Therapeutics PLC
  07 July 2008
   

 Financial Services Authority

        
 TR-1 i: NOTIFICATION OF MAJOR INTERESTS IN SHARES


 1.    Identity of the issuer or   Eirx Therapeutics Plc
 the underlying
 issuer of existing shares to
 which
 voting rights are attached ii:
 2.    Reason for notification (please tick the appropriate box or boxes)
 An acquisition or disposal of voting rights
                                                            Yes

 An acquisition or disposal of financial instruments which may result
 in the acquisition of shares already issued to which voting rights
 are attached 


 An event changing the breakdown of voting rights
                                                            Yes

 Other (please specify):


                                                                    Barclays PLC
 3.     Full name of person(s) subject to the
 notification obligation iii:

 4.     Full name of shareholder(s) (if different from 3):
    Barclays Stockbrokers Ltd
                                                                      04-Jul-08
 5.     Date of transaction and date on which the
 threshold is crossed or reached v:
                                                                      07-Jul-08
 6.     Date on which issuer notified:
                                                                      6% to 5%
 7.     Threshold(s) that is/are crossed or reached:

      

 8.     Notified details:
 A: Voting rights attached to shares

 Class/type                      Situation                          Resulting situation after the triggering transaction vii
 of shares                       previous to the
                                 Triggering
                                 transaction vi
 if possible using the ISIN
 CODE

                                 Number       Number                Number        Number of Voting Rights  % of voting
                                 Of           Of                    Of                                     rights
                                 Shares       Voting Rights viii    Shares
                                                                                  Direct x   Indirect xi   Direct   Indirect
                   GB00B0XQBS97  462,276,969           462,276,969   458,922,775          0   458,922,775     0.00      5.37

 B: Financial Instruments
 Resulting situation after the triggering transaction xii

 Type of financial instrument  Expiration  Exercise/Conversion   No. of voting         Percentage of voting
                               date xiii   Period/Date xiv       rights that may be    rights
                                                                 acquired if the
                                                                 instrument
                                                                 exercised/converted
 N/A                           N/A         N/A                   N/A                   N/A

 Total (A+B)
 Number of voting rights  Percentage of voting rights
       458,922,775                   5.37

 9.    Chain of controlled undertakings through which the voting rights and
 /or the financial instruments are effectively held, if applicable xv :
 Barclays Stockbrokers Ltd

 Proxy Voting:
 10. Name of proxy holder:                                         N/A
 11. Number of voting rights proxy holder will cease to hold:      N/A
 12. Date on which proxy holder will cease to hold voting rights:  N/A

 13. Additional information:       N/A
 14.     Contact name:             Geoff Smith
 15.     Contact telephone number  020 7116 2913


This information is provided by RNS
The company news service from the London Stock Exchange
 
  END 
 
HOLUBUSRWKRBRAR

Eirx Therapeutics (LSE:ERX)
Historical Stock Chart
From May 2024 to Jun 2024

Eirx Therapeutics (LSE:ERX)
Historical Stock Chart
From Jun 2023 to Jun 2024